Digital Mammography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

3D Full Field Digital Mammography Tomosynthesis is the fastest growing sector, North America is the largest market

The global digital mammography market is projected to expand significantly, from USD 1.19 billion in 2025 to USD 2.05 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 9.49%. This specialized diagnostic imaging technique employs solid-state detectors to convert X-ray energy into electrical signals, enabling the detection of breast abnormalities. Key growth factors include the increasing worldwide incidence of breast cancer, which demands effective early detection methods, coupled with the proliferation of government-sponsored screening initiatives. An aging female demographic also contributes to this demand, as advanced age is a primary risk factor for breast disease.

For instance, the American Cancer Society estimated 316,950 new invasive breast cancer diagnoses in U.S. women for 2025, highlighting the urgent need for accessible screening technologies.However, the market's expansion is hindered by the substantial acquisition and operational expenses linked to digital mammography systems. These considerable financial demands present a significant obstacle to market growth, especially in developing countries where healthcare budgets are often limited and reimbursement structures for advanced diagnostic procedures may be insufficient. This economic constraint restricts the widespread adoption of digital mammography units in areas with limited resources, thus impeding the technology's global accessibility.

Market Drivers

Artificial Intelligence (AI) integration in breast imaging is a pivotal driver for the Global Digital Mammography Market, significantly enhancing diagnostic accuracy and operational efficiency. By complementing human analysis with deep learning algorithms, AI helps healthcare providers reduce false positives and elevate early detection rates, thereby stimulating the uptake of advanced digital systems compatible with these sophisticated software tools. Recent clinical evidence supports this technological advantage; for instance, RadNet, Inc.'s 'AI-Supported Safeguard Review Evaluation' study in November 2025 indicated that AI-enabled workflows boosted breast cancer detection by 21.6% compared to standard 3D mammography.

These advancements motivate clinics to upgrade their equipment, enabling them to provide superior care while managing increased patient loads effectively.Simultaneously, the establishment and expansion of government-funded breast cancer screening initiatives form a consistent basis for market demand. Such national directives necessitate the broad implementation of digital mammography units to manage large-scale population screening programs efficiently, leading to predictable procurement cycles for manufacturers. For example, NHS Digital's 'Breast Screening Programme, England, 2023-24' report from February 2025 revealed that 1.95 million women aged 45 and over were screened, showcasing the significant equipment usage driven by public health policies. This high volume is crucial for addressing the rising incidence of the disease; the Canadian Cancer Society estimated 31,900 breast cancer diagnoses in Canadian women for 2025, underscoring the global need for robust and accessible digital screening infrastructure.

Market Challenges

The considerable capital expenditure necessary for digital mammography systems poses a major obstacle to the expansion of the Global Digital Mammography Market. The high acquisition costs for Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) units establish significant barriers to entry, particularly in low- and middle-income countries where healthcare budgets are severely constrained. Beyond the initial hardware procurement, the overall cost of ownership is further increased by the requirement for expensive high-resolution workstations, robust data storage infrastructure, and specialized maintenance agreements.

As a result, many healthcare facilities in resource-limited environments are compelled to continue using older analog technology, which directly impedes the broader adoption of digital solutions.This financial burden is exacerbated by inadequate reimbursement policies that often fail to sufficiently cover the operational costs associated with advanced imaging procedures. A reduction in payment rates decreases the return on investment for equipment upgrades, leading providers to postpone or abandon procurement initiatives. For instance, the American College of Radiology reported in 2025 that updated federal fee schedules led to an approximate 2.83% reimbursement cut for physician services, a financial setback that further hinders imaging centers' capacity to invest in contemporary mammography technologies.

Market Trends

A dominant hardware trend transforming the market is the extensive shift from 2D systems to 3D Digital Breast Tomosynthesis (DBT). Healthcare facilities are actively replacing their older units with DBT platforms to improve diagnostic accuracy, which significantly boosts revenue for manufacturers. This upgrade cycle is substantial; Hologic, Inc.'s 'Financial Results for Fourth Quarter of Fiscal 2024' report from November 2024 showed a 6.4% increase in Breast Health revenue, with product margin expansion directly attributed to increased sales of their 3D Dimensions systems.

As clinics increasingly favor these advanced systems, the installed base of tomosynthesis units expands, effectively phasing out 2D-only configurations.Furthermore, the adoption of density-based screening protocols has gained momentum due to regulatory changes that mandate clear patient communication regarding breast tissue composition. These updates require providers to inform women about the limitations of mammography in dense breast tissue, thereby encouraging the use of supplemental imaging modalities. This regulatory mandate was formalized by the U.S. Food and Drug Administration (FDA) in September 2024, with enforcement beginning for requirements under the 'Final Rule to Amend the Mammography Quality Standards Act (MQSA)' that facilities include specific breast density assessments in patient lay letters. This federal standardization drives demand for the additional imaging technologies needed for managing dense breast tissue.

Key Market Players

• Hologic Inc
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

Report Scope

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Mammography Market, by Product:

• 2D Full Field Digital Mammography Tomosynthesis
• 3D Full Field Digital Mammography Tomosynthesis

Digital Mammography Market, by End-User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Digital Mammography Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.